Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrest Nicholson Regulatory News (CRST)

Share Price Information for Crest Nicholson (CRST)

Share Price is delayed by 15 minutes
Get Live Data
67.70    -1.50 (-2.17%)
Bid:
67.30
Ask:
67.80
Spread: 0.50 (0.743%)
Market Cap: £173.81m
CRST Live PriceLast checked at - London Stock Exchange

Intraday Crest Nicholson Share Chart

Trading Statement

18 Nov 2025 07:00

RNS Number : 8831H
Crest Nicholson Holdings PLC
18 November 2025
 

 Crest Nicholson Holdings plc

(the "Group" or "Crest Nicholson")

Good progress on strategic priorities

Positive progress on land sales

FY25 APBT at the low end of, or marginally below, guidance

 

Crest Nicholson today provides an update on trading for the year ending 31 October 2025.

Martyn Clark, CEO commented:

"We launched our new strategic priorities at our Capital Markets Day in March this year and have made good progress in executing our transformation plan, Project Elevate. Encouragingly, progress across a number of areas is already evident, reflecting the early benefits of actions taken. We believe these will convert to positive financial contributions as we progress further in our transformation plan.

A key focus area of our strategy is the balance sheet where we have tightened our grip on inventory and cost control. We also committed to take action to address our land bank to ensure it is right-sized and better aligned to our strategy and product offering. We are therefore pleased by the positive progress on land sales on good economic terms in the second half of the year, which, in combination with our cash focus, has seen us finish the year with net debt at the better end of the guidance range of £40-90m. These land transactions support our ongoing efforts to strengthen the balance sheet and provide greater flexibility to invest in and acquire mid-premium land opportunities. This positions us well to grow our outlets in the years ahead.

Our Adjusted Profit Before Tax performance (APBT) for FY25 is expected to be at the low end of, or marginally below the guidance range of £28-38m, reflecting a housing market that has remained subdued through the summer, and the continued uncertainty surrounding Government tax policy ahead of the forthcoming Budget.

While near-term market conditions are expected to remain challenging, our enhanced operating discipline, improved balance sheet and clear strategic direction provide a robust platform to navigate the current environment and deliver long-term, sustainable growth."

FY25 trading and financial highlights

· FY25 volume 1,691 units, at the lower end of the guidance range of 1,700-1,900 units with c.35% of affordable and PRS units reflecting lower level of PRS in FY25 in line with our strategy

· Open market sales units increased by 5% to 1,095, demonstrating enhancements to our sales strategy

· FY25 open market sales rate at 0.51 (FY24: 0.48), with the sales rate for the last 13 weeks of the financial year at 0.45

· APBT expected to be at the low end of, or marginally below, the guidance range of £28m-38m

· Anticipated opening reserves adjustment to inventory of c.£8m reflecting overstated profit in relation to one development in the Eastern division between FY22 and FY24. The impact on APBT in each of those years is not expected to be material

· Year-end net debt at the better end of the guidance range of £40m-£90m with c.£50m of land receipts secured for FY26

Strategic and operational highlights

· Successful disposals of five land parcels from larger sites, in line with our land strategy

· As part of Project Elevate, a collective consultation is underway following an announcement of the proposed closure of one divisional office and selective other roles being placed at risk of redundancy across overhead functions impacting c.50 roles

· The Group is seeing some build cost inflation in line with the sector but our self-help initiatives are under way to drive better cost performance

· Notable improvements in build quality, sales performance, and customer satisfaction scores, with external recognition from NHBC and Premier for five sites

· Secured key planning wins to reinforce our high-quality strategic land pipeline, underpinning future outlet growth and margin expansion. We are seeing encouraging improvements in the planning environment with 66% of our strategic land bank now allocated or in draft allocation stage (FY24: 50%)

· Excellent progress on our new house type range, with the design phase to be finalised by December 2025

· Strengthened customer experience through enhanced training, technology investment, and improved customer journey, aligned with the expectations of the mid-premium market

· Launched the Arteva upgrade range, offering personalisation options which has generated strong interest and early financial benefits.

 

For further information, please contact:

Crest Nicholson

Jenny Matthews, Head of Investor Relations +44 (0) 7557 842720

Teneo

James Macey White / Ollie Simmonds +44 (0) 207 260 2700

 

18 November 2025

The person responsible for arranging the release of this announcement on behalf of the Company is Penny Thomas, Group Company Secretary.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTMZMMMLNLGKZM
Date   Source Headline
31st Jan 20239:40 amRNSHolding(s) in Company
30th Jan 202312:05 pmRNSDirector/PDMR Shareholding
30th Jan 202311:55 amRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSFinal Results
22nd Dec 20229:00 amRNSHolding(s) in Company
20th Dec 20224:56 pmRNSHolding(s) in Company
2nd Dec 202211:56 amRNSDirector Declaration
23rd Nov 20228:45 amRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
11th Nov 20224:00 pmRNSHolding(s) in Company
8th Nov 20223:56 pmRNSHolding(s) in Company
31st Oct 202210:37 amRNSHolding(s) in Company
21st Oct 202211:13 amRNSHolding(s) in Company
18th Oct 202210:13 amRNSHolding(s) in Company
17th Oct 20227:00 amRNSBlock listing Interim Review
17th Oct 20227:00 amRNSBlock listing Interim Review
5th Oct 20229:46 amRNSDirector/PDMR Shareholding
3rd Oct 20222:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20221:59 pmRNSDirector/PDMR Shareholding
23rd Sep 20221:59 pmRNSDirector/PDMR Shareholding
13th Sep 20229:32 amRNSDirector/PDMR Shareholding
2nd Sep 20222:09 pmRNSHolding(s) in Company
10th Aug 20223:43 pmRNSHolding(s) in Company
2nd Aug 20222:35 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSHolding(s) in Company
14th Jun 20227:00 amRNSHalf-year Report
27th May 202210:18 amRNSDirectorate Change
20th May 202210:34 amRNSHolding(s) in Company
19th Apr 202210:33 amRNSBuilding Safety Pledge
19th Apr 20229:00 amRNSBlock listing Interim Review
5th Apr 20227:00 amRNSBuilding Safety Pledge
22nd Mar 20222:14 pmRNSResult of AGM
22nd Mar 20227:00 amRNSAGM Statement
10th Mar 20228:17 amRNSDirector Declaration
28th Feb 202210:53 amRNSDirector/PDMR Shareholding
9th Feb 202211:03 amRNSAnnual Integrated Report and Notice of AGM
31st Jan 202210:38 amRNSDirector/PDMR Shareholding
31st Jan 202210:27 amRNSDirector/PDMR Shareholding
28th Jan 20223:02 pmRNSDirector/PDMR Shareholding
19th Jan 202211:38 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSFinal Results
9th Dec 20218:51 amRNSDirector Declaration
18th Nov 20217:00 amRNSTrading Statement
20th Oct 20217:00 amRNSCapital Markets Day
18th Oct 20219:00 amRNSBlock listing Interim Review
27th Jul 202112:00 pmRNSDirectorate Change
29th Jun 20214:16 pmRNSDirector/PDMR Shareholding
24th Jun 20217:00 amRNSHalf-year Report
28th May 20215:25 pmRNSHolding(s) in Company
14th May 20217:00 amRNSDisposal

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.